New Key Statistics Module, Z-Score and F-Score
NAS:HALO Key Ratios
Market Cap $ M | 4,951.30 |
Enterprise Value $ M | 6,080.25 |
P/E(ttm) | 18.45 |
PE Ratio without NRI | 17.86 |
Forward PE Ratio | 12.70 |
Price/Book | 59.00 |
Price/Sales | 6.31 |
Price/Free Cash Flow | 13.95 |
Price/Owner Earnings | 14.26 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 829.00 |
EPS (TTM) $ | 2.11 |
Beneish M-Score | -2.82 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 50.10 |
EV-to-EBIT | 16.56 |
EV-to-EBITDA | 13.45 |
PEG | -- |
Shares Outstanding M | 127.05 |
Net Margin (%) | 33.96 |
Operating Margin % | 40.71 |
Pre-tax Margin (%) | 42.01 |
Quick Ratio | 5.50 |
Current Ratio | 6.64 |
ROA % (ttm) | 15.68 |
ROE % (ttm) | 195.64 |
ROIC % (ttm) | 20.60 |
Dividend Yield % | -- |
Altman Z-Score | 3.48 |
HALO Number of Guru Trades
HALO Volume of Guru Trades
Gurus Latest Trades with NAS:HALO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HALO is held by these investors
Total 3
Halozyme Therapeutics Inc Insider Transactions
No Available Data
News about NAS:HALO
Total 0- 1